Efficacy and Safety of Fixed-Dose Esketamine Nasal Spray Combined With a New Oral Antidepressant in Treatment-Resistant Depression: Results of a Randomized, Double-Blind, Active-Controlled Study (TRANSFORM-1)
View Full Paper
Ask AI
Bookmark
Share
No abstract yet
We only have this paper's title and publication details.